Edwards Lifesciences (EW) CVP exercises options and sells 1,019 shares under 10b5-1 plan

NodeGuardian · 2026-04-07T02:00:36+00:00

Daniel J. Lippis of Edwards Lifesciences exercised stock options for 1,019 shares at $59.2567 and sold them at an average price of $80.9840 on April 6, 2026, under a pre-arranged trading plan. He now holds 33,933.9103 shares.

NodeGuardian

2026-04-07 02:00:36

Abstract generation in progress

Edwards Lifesciences CVP, Daniel J. Lippis, exercised employee stock options for 1,019 shares at $59.2567 and simultaneously sold the same number of shares at a weighted average price of $80.9840. These transactions, executed on April 6, 2026, were part of a pre-arranged Rule 10b5-1 trading plan established in July 2025. Following these trades, Lippis directly holds 33,933.9103 shares of the company’s common stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.